Avidity Biosciences (NASDAQ:RNA) reported quarterly losses of $(0.71) per share. This is a 10.94 percent decrease over losses of $(0.64) per share from the same period last year. The company reported $1.79 million in sales this quarter. This is a 33.62 percent decrease over sales of $2.70 million the same period last year.
Avidity Biosciences Q1 EPS $(0.71) Down From $(0.64) YoY, Sales $1.79M Down From $2.70M YoY
Avidity Biosciences (NASDAQ:RNA) reported quarterly losses of $(0.71) per share. This is a 10.94 percent decrease over losses of $(0.64) per share from the same period last year. The company reported $1.79 million in
Related Posts
Jushi Holdings Announces 220% YoY Spike In Q2 2021 Revenue, Updates Full Year 2021 Guidance
Vertically integrated cannabis company Jushi Holdings Inc. (CSE: JUSH) (OTCQX: JUSHF) announced its financial results on Wednesday for the second quarter of 2021, ahead of plans to open another BEYOND / HELLO shop in Philadelphia on August 31 - the 21st nationwid
Recap: Evolent Health Q4 Earnings
Evolent Health (NYSE:EVH) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:02 PM.
Here's what investors need to know about the announcement.